摘要
目的探讨抑制环氧合酶-2(COX-2)基因表达对TGF-β1诱导的人胚肺成纤维细胞系MRC-5活力、胶原合成和转化及Notch信号通路的影响。方法将MRC-5细胞分为对照组、TGF-β1组、NC组和COX-2-siRNA组,各组细胞处理48 h,Western blotting检测COX-2、胶原合成相关的COL-Ⅰ和COL-Ⅲ、 EMT标志物α-SMA及Notch信号通路受体Notch1及配体Jagged1的蛋白表达;CCK8法检测各组细胞活力。结果 TGF-β1组COX-2的表达显著高于对照组,COX-2-siRNA组COX-2的表达显著低于TGF-β1组(P<0.05),NC组COX-2的表达与TGF-β1组差异无统计学意义(P>0.05);与对照组比较,TGF-β1组细胞活力及COL-Ⅰ、COL-Ⅲ、α-SMA、Notch1和Jagged1的蛋白表达均显著升高(P<0.05),与TGF-β1组比较,COX-2-siRNA组细胞活力及COL-Ⅰ、COL-Ⅲ、α-SMA、Notch1和Jagged1的蛋白表达均显著降低(P<0.05)。结论抑制COX-2基因表达中可能通过降低MRC-5细胞活力、抑制细胞胶原合成和转化,并下调Notch信号通路,从而对肺纤维化起保护作用。
Objective To investigate the role of cyclooxygenase-2(COX-2) gene expression in TGF-β1-indcued collagen synthesis, transformation and Notch signaling in human fetal lung fibroblasts. Methods Human fetal lung fibroblasts MRC-5 cells transfected with non-targeting control or COX-2-specific siRNAs were treated with or without TGF-β1 for 48 h. Western blotting was used to detect COX-2 protein expression, alterations in the synthesis of COX-I and COX-III, and the EMT marker α-SMA, and changes in the expression of the Notch signal pathway receptor Notch1 and its cognate ligand Jagged1. Cell viability was assessed by CCK8 assay. Results COX-2 expression was significantly higher in the TGF-β1 group than the control group. Transfection of cells with COX-2-specific siRNAs significantly attenuated TGF-β1-dependent induction of COX-2 expression(P<0.05), while transfection of cells with control siRNAs had no effect. Cell viability and the expression of COX-I, COX-III, α-SMA, Notch1 and Jagged1 proteins were significantly increased in the TGF-β1 group(P<0.05), when compared with the TGF-β1 group, but were suppressed following the transfection of cells with COX-2 siRNA(P<0.05). Conclusions Inhibition of COX-2 gene expression may play a protective role in pulmonary fibrosis by reducing lung fibroblast viability and suppressing the ability of these cells to synthesize collagen and activate Notch pathway signaling.
作者
郭彩霞
于洪涛
石红梅
商玉立
GUO Caixia;YU Hongtao;SHI Hongmei;SHANG Yuli(Weifang Yi Du Central Hospital,Weifang 262500,China)
出处
《中国比较医学杂志》
CAS
北大核心
2019年第3期54-59,共6页
Chinese Journal of Comparative Medicine